<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696992</url>
  </required_header>
  <id_info>
    <org_study_id>UW18-420</org_study_id>
    <nct_id>NCT03696992</nct_id>
  </id_info>
  <brief_title>BLI, NBI or White Light Colonoscopy for Proximal Colonic Adenoma</brief_title>
  <acronym>BNW</acronym>
  <official_title>Blue Laser Imaging Versus Narrow Band Imaging Versus White Light Imaging for Detection of Adenoma in the Proximal Colon: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queen Mary Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomised trial comparing the proximal adenoma detection rate and miss
      rate by blue laser imaging (BLI), narrow band imaging or white light colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study population:

      Consecutive adult patients, age 40 or above, undergoing outpatient colonoscopy in the Queen
      Mary Hospital are invited to participate in this prospective randomized study. Patients are
      excluded if they are unable to provide informed consent or have undergone previous colorectal
      resection, or have personal history of colorectal cancer, inflammatory bowel disease,
      familial adenomatous polyposis, Peutz-Jeghers syndrome, or other polyposis syndromes.
      Patients who are considered to be unsafe for polypectomy including patients with bleeding
      tendency and those with severe comorbid illnesses will be excluded. In addition, patients are
      excluded post-randomization if either the cecum could not be intubated for various reasons or
      Boston Bowel Preparation Scale (BBPS) score is &lt;2.

      Study design and randomization:

      This is a prospective randomized crossover trial comparing the proximal adenoma detection
      rate and miss rate of BLI (ELUXEO endoscopic system) vs NBI (290 video system) vs WLI which
      is conducted in the Endoscopy Center of the Queen Mary Hospital of Hong Kong. Eligible
      patients are randomly allocated to four groups in a 1:1:1 ratio to undergo tandem colonoscopy
      of the proximal colon, defined as cecum to splenic flexure. The three groups are: (1) NBI
      follow by WLI; (2) BLI follow up WLI; (3) WLI follow by WLI. Randomization will be carried
      out by computer generated random sequences and stratified according to endoscopist's
      experiences (experienced versus fellows) and indications of colonoscopy (symptomatic vs
      screening/surveillance). All procedures are performed with high-definition endoscopes. The
      patients are blinded to the group assignment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized design</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proximal adenoma detection rate</measure>
    <time_frame>one day</time_frame>
    <description>proportion of patients with proximal adenoma detected on first examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>proximal polyp detection rate</measure>
    <time_frame>one day</time_frame>
    <description>proportion of patients with proximal polyp detected on first examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proximal adenoma miss rate</measure>
    <time_frame>one day</time_frame>
    <description>proportion of patients with proximal adenoma detected on second examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proximal polyp miss rate</measure>
    <time_frame>one day</time_frame>
    <description>proportion of patients with proximal polyp detected on second examination</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">894</enrollment>
  <condition>Colon Adenoma</condition>
  <arm_group>
    <arm_group_label>NBI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tandem colonoscopy with NBI follow by WL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BLI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tandem colonoscopy with BLI follow by WLI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WLI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tandem colonoscopy with WLI follow by WL</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tandem colonoscopy</intervention_name>
    <description>Tandem colonoscopy with different image modalities</description>
    <arm_group_label>BLI</arm_group_label>
    <arm_group_label>NBI</arm_group_label>
    <arm_group_label>WLI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40 or above

          -  scheduled for colonoscopy

        Exclusion Criteria:

          -  unable to provide informed consent

          -  have undergone previous colorectal resection,

          -  personal history of colorectal cancer, inflammatory bowel disease, familial
             adenomatous polyposis, Peutz-Jeghers syndrome, or other polyposis syndromes.

          -  Patients who are considered to be unsafe for polypectomy including patients with
             bleeding tendency and those with severe comorbid illnesses

          -  poor bowel preparation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wai Keung Leung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wai Keung Leung, MD</last_name>
    <phone>+852 22553348</phone>
    <email>waikleung@hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Lui, MBBS</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2018</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>LEUNG Wai Keung</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

